News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
136,714 Results
Type
Article (4371)
Company Profile (95)
Press Release (132243)
Multimedia
Podcasts (4)
Webinars (7)
Section
Business (42115)
Career Advice (210)
Deals (6167)
Drug Delivery (15)
Drug Development (17447)
Employer Resources (18)
FDA (1507)
Job Trends (2791)
News (66290)
Policy (3660)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (294)
Accelerated approval (8)
Adcomms (1)
Allergies (34)
Alliances (11516)
ALS (54)
Alzheimer's disease (435)
Antibody-drug conjugate (ADC) (102)
Approvals (1594)
Artificial intelligence (105)
Autoimmune disease (64)
Automation (13)
Bankruptcy (38)
Best Places to Work (2251)
BIOSECURE Act (14)
Biosimilars (25)
Biotechnology (86)
Bladder cancer (44)
Brain cancer (13)
Breast cancer (192)
Cancer (1367)
Cardiovascular disease (50)
Career advice (202)
Career pathing (5)
CAR-T (127)
Cell therapy (324)
Cervical cancer (9)
Clinical research (15463)
Collaboration (569)
Compensation (282)
Complete response letters (5)
COVID-19 (443)
CRISPR (25)
C-suite (374)
Cystic fibrosis (45)
Data (1976)
Depression (21)
Diabetes (105)
Diagnostics (767)
Digital health (1)
Diversity, equity & inclusion (8)
Drug discovery (95)
Drug pricing (9)
Drug shortages (2)
Duchenne muscular dystrophy (51)
Earnings (13380)
Editorial (5)
Employer resources (18)
Events (26392)
Executive appointments (388)
FDA (2206)
Fibrodysplasia Ossificans Progressiva (3)
Frontotemporal dementia (14)
Funding (481)
Gene editing (54)
Generative AI (12)
Gene therapy (170)
GLP-1 (165)
Government (363)
Guidances (71)
Healthcare (1541)
HIV (9)
Huntington's disease (12)
IgA nephropathy (40)
Immunology and inflammation (70)
Immuno-oncology (14)
Indications (27)
Infectious disease (502)
Inflammatory bowel disease (76)
Inflation Reduction Act (1)
Influenza (37)
Intellectual property (79)
Interviews (18)
IPO (2968)
IRA (4)
Job creations (668)
Job search strategy (185)
JPM (3)
Kidney cancer (3)
Labor market (16)
Layoffs (42)
Leadership (2)
Legal (641)
Liver cancer (16)
Longevity (2)
Lung cancer (127)
Lymphoma (145)
Machine learning (15)
Management (4)
Manufacturing (248)
MASH (19)
Medical device (407)
Medtech (409)
Mergers & acquisitions (3540)
Metabolic disorders (228)
Multiple sclerosis (54)
NASH (1)
Neurodegenerative disease (82)
Neuropsychiatric disorders (15)
Neuroscience (768)
Neurotech (1)
NextGen: Class of 2026 (860)
Non-profit (280)
Now hiring (7)
Obesity (97)
Opinion (41)
Ovarian cancer (69)
Pain (44)
Pancreatic cancer (74)
Parkinson's disease (105)
Partnered (6)
Patents (134)
Patient recruitment (161)
Peanut (17)
People (17161)
Pharmaceutical (8)
Phase 1 (6099)
Phase 2 (7397)
Phase 3 (3812)
Pipeline (1500)
Policy (33)
Postmarket research (210)
Preclinical (2636)
Press Release (51)
Prostate cancer (49)
Psychedelics (5)
Radiopharmaceuticals (51)
Rare diseases (169)
Real estate (1462)
Recruiting (10)
Regulatory (3457)
Reports (15)
Research institute (312)
Resumes & cover letters (20)
Rett syndrome (9)
RNA editing (4)
RSV (13)
Schizophrenia (17)
Series A (92)
Series B (75)
Service/supplier (2)
Sickle cell disease (24)
Special edition (3)
Spinal muscular atrophy (40)
Sponsored (5)
Startups (991)
State (1)
Stomach cancer (2)
Supply chain (22)
Tariffs (9)
The Weekly (4)
Vaccines (127)
Venture capital (19)
Weight loss (41)
Women's health (9)
Worklife (2)
Date
Today (6)
Last 7 days (153)
Last 30 days (524)
Last 365 days (8474)
2026 (944)
2025 (8550)
2024 (9163)
2023 (9894)
2022 (12010)
2021 (12656)
2020 (9857)
2019 (6693)
2018 (5282)
2017 (6081)
2016 (5595)
2015 (6443)
2014 (4925)
2013 (4068)
2012 (4409)
2011 (4879)
2010 (4517)
Location
Africa (144)
Alabama (52)
Alaska (1)
Arizona (36)
Arkansas (2)
Asia (8948)
Australia (2080)
California (3664)
Canada (913)
China (280)
Colorado (73)
Connecticut (128)
Delaware (56)
Europe (19579)
Florida (384)
Georgia (54)
Hawaii (2)
Idaho (11)
Illinois (180)
India (18)
Indiana (196)
Iowa (3)
Japan (106)
Kansas (15)
Kentucky (3)
Louisiana (3)
Maine (2)
Maryland (377)
Massachusetts (2761)
Michigan (97)
Minnesota (158)
Mississippi (1)
Missouri (11)
Montana (11)
Nebraska (2)
Nevada (23)
New Hampshire (7)
New Jersey (684)
New Mexico (6)
New York (807)
North Carolina (446)
North Dakota (5)
Northern California (1805)
Ohio (68)
Oklahoma (7)
Oregon (7)
Pennsylvania (634)
Puerto Rico (9)
Rhode Island (6)
South America (202)
South Carolina (4)
Southern California (1444)
Tennessee (23)
Texas (480)
United States (11529)
Utah (35)
Virginia (27)
Washington D.C. (9)
Washington State (507)
West Virginia (1)
Wisconsin (23)
136,714 Results for "maia biotechnology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
MAIA Biotechnology Announces $1.51 Million Private Placement
December 17, 2025
·
4 min read
Press Releases
MAIA Biotechnology Board Members Continue to Participate in Private Placement Financings
December 25, 2025
·
5 min read
Press Releases
MAIA Biotechnology Announces Open Market Purchases by CEO and Directors
December 2, 2025
·
3 min read
Press Releases
MAIA Biotechnology Advances Ateganosine Cancer Treatment Program, Outlines Targeted 2026 Clinical Milestones and Growth Momentum
January 21, 2026
·
7 min read
Press Releases
MAIA Biotechnology Highlights Ongoing Momentum of Ateganosine Clinical Program at SITC 2025
November 24, 2025
·
8 min read
Press Releases
MAIA Biotechnology Announces $736,600 Private Placement
October 14, 2025
·
4 min read
Press Releases
MAIA’s Ateganosine Surges Ahead with Breakthrough Momentum as Pivotal Phase 3 Trial Initiates
December 12, 2025
·
5 min read
Press Releases
MAIA Biotechnology Announces $2.25 Million Private Placement
September 29, 2025
·
4 min read
Press Releases
MAIA Biotechnology CEO Presents Telomere Targeting Efficacy at Romania’s 2025 Smart Diaspora Conference on Oncology Research and Innovation
November 21, 2025
·
6 min read
Press Releases
MAIA Biotechnology Announces First Patient Dosed in THIO-104 Phase 3 Pivotal Trial Evaluating Ateganosine as Third-Line Treatment for Advanced Non-Small Cell Lung Cancer
December 12, 2025
·
6 min read
1 of 13,672
Next
